Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.21 USD
Change Today +0.0124 / 6.20%
Volume 30.4K
As of 8:10 PM 04/27/15 All times are local (Market data is delayed by at least 15 minutes).

kips bay medical inc (KIPS) Snapshot

Open
$0.20
Previous Close
$0.20
Day High
$0.21
Day Low
$0.20
52 Week High
05/6/14 - $0.66
52 Week Low
12/10/14 - $0.12
Market Cap
7.0M
Average Volume 10 Days
44.3K
EPS TTM
$-0.17
Shares Outstanding
33.0M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for KIPS BAY MEDICAL INC (KIPS)

Related News

No related news articles were found.

kips bay medical inc (KIPS) Related Businessweek News

No Related Businessweek News Found

kips bay medical inc (KIPS) Details

Kips Bay Medical, Inc., a medical device company, develops, manufactures, and commercializes external saphenous vein support technology (eSVS Mesh), for use in coronary artery bypass grafting (CABG) surgery. Its eSVS Mesh is designed to be fitted like a sleeve on the outside of saphenous vein grafts (SVG) to strengthen SVGs used in CABG surgery. The company markets its eSVS MESH through independent distributors in selected European Union markets. Kips Bay Medical, Inc. was founded in 2007 and is based in Minneapolis, Minnesota.

8 Employees
Last Reported Date: 03/12/15
Founded in 2007

kips bay medical inc (KIPS) Top Compensated Officers

Founder, Chairman and Chief Executive Officer
Total Annual Compensation: $377.9K
Chief Financial Officer, Chief Operating Offi...
Total Annual Compensation: $239.5K
Vice President of Regulatory & Clinical Affai...
Total Annual Compensation: $246.7K
Compensation as of Fiscal Year 2014.

kips bay medical inc (KIPS) Key Developments

Kips Bay Medical, Inc. Announces Unaudited Earnings Results for the Fourth Quarter and Twelve Ended December 31, 2014

Kips Bay Medical, Inc. announced unaudited earnings results for the fourth quarter and twelve ended December 31, 2014. For the quarter, the company’s net sales were $14,000, down from $41,000 in the fourth quarter of 2013. Net loss was $1.3 million, or $0.04 per diluted share, compared to a net loss of $1.5 million, or $0.06 per diluted share, in the fourth quarter of 2013. For the year, the company’s net sales for the full years of 2014 and 2013 were $84,000 and $130,000, respectively. The net loss was $5.6 million, or $0.17 per diluted share, compared to a net loss of $6.1 million, or $0.23 per diluted share, for the year ended December 31, 2013. Cash used in operations decreased from $5.5 million for the year ended December 31, 2013 to $5.0 million for the year ended December 31, 2014. This decrease was due to a reduction in the company's net loss for 2014 and the effects of changes in non-cash stock-based compensation, depreciation and operating assets and liabilities. Purchase of property and equipment was $2,000 against $17,000 a year ago.

Kips Bay Medical, Inc. Auditor Raises 'Going Concern' Doubt

Kips Bay Medical, Inc. filed its 10-K on Mar 12, 2015 for the period ending Dec 31, 2014. In this report its auditor, Ernst & Young LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.

Kips Bay Medical, Inc. Announces Unaudited Earnings Results for the Third Quarter and Nine Months Ended September 27, 2014

Kips Bay Medical, Inc. announced unaudited earnings results for the third quarter and nine months ended September 27, 2014. For the quarter, the company reported net sales of $13,000 compared with $13,000 for the same period a year ago. Net loss was $1,424,000 or $0.04 per basic and diluted share compared with $1,566,000 or $0.06 per basic and diluted share for the same period a year ago. Operating loss was $1,425,000 compared to $1,570,000 in the same period last year. For the nine months, the company reported net sales of $71,000 compared with $89,000 for the same period a year ago. Net loss was $4,289,000 or $0.13 per basic and diluted share compared with $4,526,000 or $0.17 per basic and diluted share for the same period a year ago. Operating loss was $4,294,000 compared to $4,538,000 in the same period last year. Net cash used in operating activities was $3,856,000 compared with $4,317,000 for the same period a year ago. Purchase of property and equipment was $2,000 compared with $17,000 for the same period a year ago. The decrease in net sales for the nine month comparison reflects the negative impact of the limited amount of clinical data on the performance of the eSVS Mesh, limited reimbursements available to hospitals and the continuing effects of economic difficulties in certain European countries.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
KIPS:US $0.21 USD +0.0124

KIPS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for KIPS.
View Industry Companies
 

Industry Analysis

KIPS

Industry Average

Valuation KIPS Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 78.6x
Price/Book 1.5x
Price/Cash Flow NM Not Meaningful
TEV/Sales 35.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact KIPS BAY MEDICAL INC, please visit www.kipsbaymedical.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.